AAS
VNRX icon

Ameritas Advisory Services’s VolitionRx Ltd VNRX Stock Holding History

Ameritas Advisory Services’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$2.71K – 2087
2025
Q3 		$2.71K Hold
200
– – ﹤0.01% 1942
2025
Q2 		$3.04K Buy
+200
New +$2.21K ﹤0.01% 2391

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameritas Advisory Services's VNRX Position: Q4 2025 in Review

Ameritas Advisory Services sold out of VolitionRx Ltd (VNRX) in Q4 2025, closing a stake of 200 shares — an estimated $2.71K sold.

Ameritas Advisory Services first reported a position in VNRX in Q2 2025 and held it in 2 quarters. The position peaked at $3.04K in Q2 2025. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.

  • Ameritas Advisory Services reported no remaining VolitionRx Ltd position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 200 VolitionRx Ltd shares in Q4 2025, an estimated $2.71K.
  • Ameritas Advisory Services first reported a position in VolitionRx Ltd in Q2 2025 and held it in 2 quarters.
  • Ameritas Advisory Services's VolitionRx Ltd position peaked at $3.04K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.